Alto Neuroscience, Inc. (ANRO) Misses Q3 EPS by 6c
Tweet
Share
E-mailGet Alerts ANRO Hot Sheet
Join SI Premium – FREE
Alto Neuroscience, Inc. (NYSE: ANRO) reported Q3 EPS of ($0.62), $0.06 worse than the analyst estimate of ($0.56).
For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nucor projects Q3 2026 earnings above prior year, below estimates
- Alphabet (GOOGL) PT Raised to $485 at Tigress Financial Partners
- Disney names Adam Smith chairman of direct-to-consumer unit
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
